Donatella Labella
Impact in
-
- Epigenetics and DNA Methylation
- Histone Deacetylase Inhibitors Research
- Cancer-related gene regulation
- Protein Degradation and Inhibitors
- RNA modifications and cancer
-
- Synthesis and biological activity
- Click Chemistry and Applications
- Synthesis and Biological Evaluation
Papers in
-
- Epigenetics and DNA Methylation 6
- Histone Deacetylase Inhibitors Research 4
- Genomics and Chromatin Dynamics 2
- Cancer-related gene regulation 2
- Protein Degradation and Inhibitors 2
- DNA Repair Mechanisms 1
- Oncology 3
- Peptidase Inhibition and Analysis 2
- Co-authors
- Antonello Mai (8 shared papers)Sérgio Valente (6 shared papers)Lucia Altucci (3 shared papers)Dante Rotili (3 shared papers)Donatella Del Bufalo (2 shared papers)Daniela Trisciuoglio (2 shared papers)Gerald Brosch (1 shared paper)Giulio Dondio (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (2 papers)ACS Medicinal Chemistry Letters (1 paper)ChemMedChem (1 paper)Journal of Biological Chemistry (1 paper)European Journal of Medicinal Chemistry (1 paper)
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
Donatella Labella
8 papers receiving 388 citations
Peers
Comparison fields: 5 of 51
- Molecular Biology 286
- Organic Chemistry 111
- Toxicology 7
- Cancer Research 25
- Oncology 35
Countries citing papers authored by Donatella Labella
This map shows the geographic impact of Donatella Labella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donatella Labella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donatella Labella more than expected).
Fields of papers citing papers by Donatella Labella
This network shows the impact of papers produced by Donatella Labella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donatella Labella. The network helps show where Donatella Labella may publish in the future.
Co-authors
The 25 scholars most cited alongside Donatella Labella, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 123 | |
| 2 | 2013 | 96 | |
| 3 | 2014 | 51 | |
| 4 | 2011 | 42 | |
| 5 | 2014 | 30 | |
| 6 | 2015 | 24 | |
| 7 | 2013 | 17 | |
| 8 | 2014 | 14 |
About Donatella Labella
Donatella Labella is a scholar working on Molecular Biology, Oncology, Virology, Genetics and Infectious Diseases, having authored 8 papers that have together received 397 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (6 papers), Histone Deacetylase Inhibitors Research (4 papers), Genomics and Chromatin Dynamics (2 papers), Cancer-related gene regulation (2 papers), Protein Degradation and Inhibitors (2 papers), Peptidase Inhibition and Analysis (2 papers), DNA Repair Mechanisms (1 paper) and Estrogen and related hormone effects (1 paper). The work is most often cited by research in Molecular Biology (286 citations), Organic Chemistry (111 citations), Toxicology (7 citations), Cancer Research (25 citations) and Oncology (35 citations). Donatella Labella has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Antonello Mai, Sérgio Valente, Lucia Altucci, Dante Rotili, Donatella Del Bufalo, Daniela Trisciuoglio, Gerald Brosch, Giulio Dondio, Marco Miceli and Teresa De Luca. Their work appears in journals such as Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters, ChemMedChem, Journal of Biological Chemistry and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.